dr. Kai Ling Liang (PhD)

CRIG member
Kai Ling Liang


Postdoctoral researcher – Faculty of Medicine and Health Sciences, Prof. Tom Taghon’s group, UGent.
Principal investigator: prof. Tom Taghon (PhD)

 

Research team

The thymus is an organ where T-cell development takes place. The process is sustained by the continuous seeding of hematopoietic progenitors that originate from the bone marrow. These early thymic progenitors (ETPs) possess both myeloid and lymphoid developmental potentials.
My research aims to delineate the molecular mechanisms that underlie the lineage fate choice and stepwise differentiation of human early thymic progenitors (ETPs). This allows us to understand how dysregulation of normal T-cell development contributes to the leukemogenesis of T-cell acute lymphoblastic leukemia and to identify potential therapeutic targets.
Besides that, I am also assessing the impact of potential anti-leukemic compounds on human normal T-cell development.      
 

Key publications

  • "TRIB2 regulates normal and stress-induced thymocyte proliferation". Cell Discovery, 2016. (PMID: 27462446) 
  • “Tribbles in acute leukemia”. Blood, 2013. (PMID: 23550039)
  • “Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate”. International Journal of Hematology, 2011. (PMID: 21387093)
     

Contact & links

  • Lab address: GE32, Building MRB2 (entrance 38), UZ campus
  • LinkedIn
  • Kai Ling Liang is interested to receive invitations for presentations or talks